If your browser is equipped with a CML aware plug-in, then the CML will be processed to render a 2D or 3D model of the molecular structure.
If your browser is NOT CML aware, then you can use the "Jumbo3" program included on the cdrom, to render the CML file.
Select from
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
3-((4-Methyl-1-piperazinyl)iminomethyl)rifamycin SV | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
3-(4-Benzyl-2,6-dimethylpiperazinoiminomethyl)rifamycin SV | Oc1c(C=NN2C(C)CN(CC2C)Cc3ccccc3)c4NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC5(C)Oc6c(C)c(O)c(c4O)c1c6C5=O |
3-Formyl rifamycin SV O-3-phenylpropyl oxime | Oc1c(C=NOCCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
3-Propylaminomethyl rifamycin SV | Oc1c(CNCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
3-Propylaminomethyl_rifamycin_SV | Oc1c(CNCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
8-(((4-Methylpiperazinyl)imino)methyl)rifamycin sv | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Monosodium rifamycin SV | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
N,15-Didehydro-15-deoxo-3,15-epi(methano(imino))rifamycin SV | Oc1c2CNC3=Nc2c(O)c4c(O)c(C)c5OC(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C3C)C(=O)c5c14 |
N,15-Didehydro-15-deoxo-3,15-epi(methano(methylimino))rifamycin SV | Oc1c2CN(C)C3=Nc2c(O)c4c(O)c(C)c5OC(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C3C)C(=O)c5c14 |
N_15-Didehydro-15-deoxo-3_15-epi(methano(imino))rifamycin_SV | Oc1c2CNC3=Nc2c(O)c4c(O)c(C)c5OC(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C3C)C(=O)c5c14 |
N_15-Didehydro-15-deoxo-3_15-epi(methano(methylimino))rifamycin_SV | Oc1c2CN(C)C3=Nc2c(O)c4c(O)c(C)c5OC(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C3C)C(=O)c5c14 |
RIFAMYCIN SV | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
Rifamycin AF 013 | Oc1c(C=NOCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin AF 05 | Oc1c(C=NOC(c2ccccc2)c3ccccc3)c4NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC5(C)Oc6c(C)c(O)c(c4O)c1c6C5=O |
Rifamycin AF/01 | Oc1c(C=NOCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin AF/MO | Oc1c(C=NOC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin AF/O9 | Oc1c(C=NOC(C)C)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin AMP | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin B N, N-diethylamide | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B N,N-diethylamide derivative | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B azepinide | O(CC(=O)N1CCCCCC1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin B butyldimethylhydrazide | O(CC(=O)N(CCCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B butylmethylamide | O(CC(=O)N(C)CCCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B butylpiperidinylamide | O(CC(=O)N(CCCC)N1CCCCC1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin B diallylamide | O(CC(=O)N(CC=C)CC=C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B dibutylmethylhydrazide | O(CC(=O)N(C)N(CCCC)CCCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B diethylamide | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B diethylmethylhydrazide | O(CC(=O)N(C)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B diethylpropylhydrazide | O(CC(=O)N(CCC)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B diisobutylamide | O(CC(=O)N(CC(C)C)CC(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B dimethylamylhydrazide | O(CC(=O)N(CCCCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B dimethylpropylhydrazide | O(CC(=O)N(CCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B dipropylethylhydrazide | O(CC(=O)N(CC)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B dipropylmethylhydrazide | O(CC(=O)N(C)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B ethylphenylamide | O(CC(=O)N(CC)c1ccccc1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin B triethylhydrazide | O(CC(=O)N(CC)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B trimethylhydrazide | O(CC(=O)N(C)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B tripropylhydrazide | O(CC(=O)N(CCC)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B | O(CC(=O)O)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin B, N,N-diethylamide | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin M-14 | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin M14 | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin O | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)NC4=CC5(OCC(=O)O5)c2c(c(O)c3C)C4=O |
Rifamycin S 15-iminomethyl ether | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(OC)=NC4=CC(=O)c2c(c(O)c3C)C4=O |
Rifamycin S | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)NC4=CC(=O)c2c(c(O)c3C)C4=O |
Rifamycin SV | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
Rifamycin W | O=C1C=C2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O)C(C)C(O)C(CO)C=C(C)C(=O)c3c(O)c(C)c(O)c(C2=O)c13 |
Rifamycin amp | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin cis-AF/ABDP | Oc1c(C=NN2C(C)CN(CC2C)Cc3ccccc3)c4NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC5(C)Oc6c(C)c(O)c(c4O)c1c6C5=O |
Rifamycin diethylamide | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin sodium salt | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
Rifamycin | O(CC(=O)O)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 1,4-dideoxy-1, 4-dihydro-1,4-dioxo- | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)NC4=CC(=O)c2c(c(O)c3C)C4=O |
Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-, 8-acetate | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)NC4=CC(=O)c2c(C4=O)c(OC(C)=O)c3C |
Rifamycin, 3-(((1-methylethoxy)imino)methyl)- | Oc1c(C=NOC(C)C)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-(((2-(1-piperidinyl)ethoxy)imino)methyl)- | Oc1c(C=NOCCN2CCCCC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-(((2-phenylethoxy)imino)methyl)- | Oc1c(C=NOCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-(((3-phenylpropoxy)imino)methyl)- | Oc1c(C=NOCCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)- | Oc1c(C=NN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-(((decyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-(((diphenylmethoxy)imino)methyl)- | Oc1c(C=NOC(c2ccccc2)c3ccccc3)c4NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC5(C)Oc6c(C)c(O)c(c4O)c1c6C5=O |
Rifamycin, 3-(((nonyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-(((octyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-(((pentyloxy)imino)methyl)- | Oc1c(C=NOCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-(((phenylmethoxy)imino)methyl)- | Oc1c(C=NOCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-(((undecyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-((1-piperazinylimino)methyl)- | Oc1c(C=NN2CCNCC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-((4-methyl-1-piperazinyl)methyl)- | Oc1c(CN2CCN(C)CC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin, 3-((butoxyimino)methyl)- | Oc1c(C=NOCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-((ethoxyimino)methyl)- | Oc1c(C=NOCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-((hydroxyimino)methyl)- | Oc1c(C=NO)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-((methoxyimino)methyl)- | Oc1c(C=NOC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 3-((propoxyimino)methyl)- | Oc1c(C=NOCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(1-butyl-2,2-dimethylhydrazino)-2-oxoethyl)- | O(CC(=O)N(CCCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(1-ethyl-2,2-dipropylhydrazino)-2-oxoethyl)- | O(CC(=O)N(CC)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(1-methyl-2,2-dipropylhydrazino)-2-oxoethyl)- | O(CC(=O)N(C)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(2,2-dibutyl-1-methylhydrazino)-2-oxoethyl)- | O(CC(=O)N(C)N(CCCC)CCCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(2,2-diethyl-1-methylhydrazino)-2-oxoethyl)- | O(CC(=O)N(C)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(2,2-diethyl-1-propylhydrazino)-2-oxoethyl)- | O(CC(=O)N(CCC)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(2,2-dimethyl-1-pentylhydrazino)-2-oxoethyl)- | O(CC(=O)N(CCCCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(2,2-dimethyl-1-propylhydrazino)-2-oxoethyl)- | O(CC(=O)N(CCC)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(bis(2-methylpropyl)amino)-2-oxoethyl)- | O(CC(=O)N(CC(C)C)CC(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(butyl-1-piperidinylamino)-2-oxoethyl)- | O(CC(=O)N(CCCC)N1CCCCC1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin, 4-O-(2-(butylmethylamino)-2-oxoethyl)- | O(CC(=O)N(C)CCCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(di-2-propenylamino)-2-oxoethyl)- | O(CC(=O)N(CC=C)CC=C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(diethylamino)-2-oxoethyl)- | O(CC(=O)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-(ethylphenylamino)-2-oxoethyl)- | O(CC(=O)N(CC)c1ccccc1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin, 4-O-(2-(hexahydro-1H-azepin-1-yl)-2-oxoethyl)- | O(CC(=O)N1CCCCCC1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Rifamycin, 4-O-(2-oxo-2-(triethylhydrazino)ethyl)- | O(CC(=O)N(CC)N(CC)CC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-oxo-2-(trimethylhydrazino)ethyl)- | O(CC(=O)N(C)N(C)C)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(2-oxo-2-(tripropylhydrazino)ethyl)- | O(CC(=O)N(CCC)N(CCC)CCC)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, 4-O-(carboxymethyl)- | O(CC(=O)O)c1cc2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin, monosodium salt | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
Rifamycin_SV | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)Nc4cc(O)c2c(c(O)c3C)c4O |
Rifamycin_S_15-iminomethyl_ether | O=C1c2c3OC1(C)OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(OC)=NC4=CC(=O)c2c(c(O)c3C)C4=O |
Rifamycin_W | O=C1C=C2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O)C(C)C(O)C(CO)C=C(C)C(=O)c3c(O)c(C)c(O)c(C2=O)c13 |
Rifamycin__3-(((1-methylethoxy)imino)methyl)- | Oc1c(C=NOC(C)C)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-(((2-phenylethoxy)imino)methyl)- | Oc1c(C=NOCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin__3-(((3-phenylpropoxy)imino)methyl)- | Oc1c(C=NOCCCc2ccccc2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin__3-(((decyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-(((diphenylmethoxy)imino)methyl)- | Oc1c(C=NOC(c2ccccc2)c3ccccc3)c4NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC5(C)Oc6c(C)c(O)c(c4O)c1c6C5=O |
Rifamycin__3-(((nonyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-(((octyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-(((pentyloxy)imino)methyl)- | Oc1c(C=NOCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-(((undecyloxy)imino)methyl)- | Oc1c(C=NOCCCCCCCCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-((1-piperazinylimino)methyl)- | Oc1c(C=NN2CCNCC2)c3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c1c5C4=O |
Rifamycin__3-((butoxyimino)methyl)- | Oc1c(C=NOCCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-((ethoxyimino)methyl)- | Oc1c(C=NOCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |
Rifamycin__3-((propoxyimino)methyl)- | Oc1c(C=NOCCC)c2NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC3(C)Oc4c(C)c(O)c(c2O)c1c4C3=O |